First Time Loading...

Alphamab Oncology
HKEX:9966

Watchlist Manager
Alphamab Oncology Logo
Alphamab Oncology
HKEX:9966
Watchlist
Price: 5.19 HKD -0.76% Market Closed
Updated: May 5, 2024

Alphamab Oncology
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Alphamab Oncology
Cash from Operating Activities Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Alphamab Oncology
HKEX:9966
Cash from Operating Activities
-¥300.3m
CAGR 3-Years
5%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Cash from Operating Activities
-¥7.8B
CAGR 3-Years
-12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Cash from Operating Activities
-¥1.7B
CAGR 3-Years
-78%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Cash from Operating Activities
¥1.5B
CAGR 3-Years
49%
CAGR 5-Years
49%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Cash from Operating Activities
¥3.6B
CAGR 3-Years
3%
CAGR 5-Years
106%
CAGR 10-Years
47%
Imeik Technology Development Co Ltd
SZSE:300896
Cash from Operating Activities
¥1.2B
CAGR 3-Years
57%
CAGR 5-Years
70%
CAGR 10-Years
N/A

See Also

What is Alphamab Oncology's Cash from Operating Activities?
Cash from Operating Activities
-300.3m CNY

Based on the financial report for Dec 31, 2023, Alphamab Oncology's Cash from Operating Activities amounts to -300.3m CNY.

What is Alphamab Oncology's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-29%

Over the last year, the Cash from Operating Activities growth was 0%. The average annual Cash from Operating Activities growth rates for Alphamab Oncology have been 5% over the past three years , -29% over the past five years .